Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07BMX
|
|||
| Former ID |
DNC012965
|
|||
| Drug Name |
(S)-2-amino-3-(benzylthio)propanoic acid
|
|||
| Synonyms |
H-D-Cys(Bzl)-OH; 23032-53-3; S-benzyl-D-cysteine; (S)-Benzyl-D-Cys; CHEMBL204162; CCRIS 1971; Alanine, 3-(benzylthio)-, L-; EINECS 221-273-4; (S)-2-AMINO-3-(S-BENZYLTHIO)PROPANOIC ACID; AC1Q5R1B; AC1L2QY5; SCHEMBL1927561; D-Cysteine, S-(phenylmethyl)-; CTK7D0951; MolPort-005-937-279; GHBAYRBVXCRIHT-SECBINFHSA-N; ZINC404299; BDBM50179697; AS-49045; AJ-22311; AX8012175; LS-188299
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H13NO2S
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CSCC(C(=O)O)N
|
|||
| InChI |
1S/C10H13NO2S/c11-9(10(12)13)7-14-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m1/s1
|
|||
| InChIKey |
GHBAYRBVXCRIHT-SECBINFHSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated calcium channel alpha-2/delta-1 (CACNA2D1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | MAPK signaling pathway | |||
| Cardiac muscle contraction | ||||
| Adrenergic signaling in cardiomyocytes | ||||
| Oxytocin signaling pathway | ||||
| Hypertrophic cardiomyopathy (HCM) | ||||
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | ||||
| Dilated cardiomyopathy | ||||
| Panther Pathway | Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||
| WikiPathways | Arrhythmogenic Right Ventricular Cardiomyopathy | |||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.